Shoulder Innovations Amends S-1, Signals Imminent IPO
Ticker: SI · Form: S-1/A · Filed: Jul 25, 2025 · CIK: 1699350
| Field | Detail |
|---|---|
| Company | Shoulder Innovations, Inc. (SI) |
| Form Type | S-1/A |
| Filed Date | Jul 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: S-1/A, IPO, Medical Devices, Orthopedics, SEC Filing, Emerging Growth Company, Healthcare
TL;DR
**SHOULDER INNOVATIONS is gearing up for an IPO, making it a speculative buy for growth-hungry investors in the medical device space.**
AI Summary
SHOULDER INNOVATIONS, INC. filed an S-1/A on July 25, 2025, as Amendment No. 3 to its S-1 Registration Statement, indicating an upcoming public offering. The company, classified under Surgical & Medical Instruments & Apparatus (SIC 3841), is based in Grand Rapids, Michigan. While specific revenue and net income figures are not detailed in this excerpt, the filing signals a strategic move towards public capital markets to fund its operations and growth initiatives in the medical device sector. Key business changes include the formalization of its intent to sell securities to the public, as soon as practicable after the effective date of the Registration Statement. Risks associated with this offering would typically involve market acceptance of its medical devices and the competitive landscape, though specific risks are not enumerated in this snippet. The strategic outlook is focused on leveraging public funding to expand its market presence and product development in shoulder innovation.
Why It Matters
This S-1/A filing is a critical step for Shoulder Innovations, Inc., signaling its intent to go public and raise capital, which could fuel innovation in the orthopedic medical device market. For investors, it represents a new opportunity in a specialized healthcare segment, though competition from established players like Zimmer Biomet and Stryker is intense. Employees could see increased opportunities and potential stock-based compensation, while customers might benefit from accelerated product development and wider availability of advanced shoulder solutions. The broader market gains a new publicly traded entity in the medical instruments sector, potentially driving further M&A activity and technological advancements.
Risk Assessment
Risk Level: medium — The risk level is medium because while the S-1/A indicates a move towards public offering, specific financial performance, competitive challenges, and regulatory hurdles are not detailed in this excerpt. The company operates in the highly regulated and competitive medical device industry (SIC 3841), which inherently carries significant market and operational risks, even without explicit numbers cited in this snippet.
Analyst Insight
Investors should closely monitor subsequent filings for detailed financials, competitive analysis, and specific use of proceeds. Consider a small, speculative position only after a thorough review of the full S-1, focusing on market size, product differentiation, and management's experience in the orthopedic sector.
Financial Highlights
- debt To Equity
- X.X
- revenue
- $X
- operating Margin
- X%
- total Assets
- $X
- total Debt
- $X
- net Income
- $X
- eps
- $X
- gross Margin
- X%
- cash Position
- $X
- revenue Growth
- +X%
Executive Compensation
| Name | Title | Total Compensation |
|---|---|---|
| Robert Ball | Chief Executive Officer and Executive Chairman | $X |
| Jeffrey Points | Chief Financial Officer | $X |
Key Numbers
- 3841 — Standard Industrial Classification Code (Identifies the company as a Surgical & Medical Instruments & Apparatus manufacturer.)
- 2025-07-25 — Filing Date (Date the S-1/A was filed with the SEC.)
- 3 — Amendment Number (This is the third amendment to the original S-1 Registration Statement.)
- 0001699350 — Central Index Key (CIK) (Unique identifier for SHOULDER INNOVATIONS, INC. with the SEC.)
- 27-0538764 — IRS Employer Identification Number (EIN) (Tax identification number for the company.)
Key Players & Entities
- SHOULDER INNOVATIONS, INC. (company) — Registrant for S-1/A filing
- Robert Ball (person) — Chief Executive Officer and Executive Chairman
- Jeffrey Points (person) — Chief Financial Officer
- Latham & Watkins LLP (company) — Legal counsel for registrant
- Cooley LLP (company) — Legal counsel for registrant
- Honigman LLP (company) — Legal counsel for registrant
- U.S. Securities and Exchange Commission (regulator) — Receiving body for S-1/A filing
- Delaware (regulator) — State of incorporation
- 333-288549 (regulator) — SEC File Number for the S-1 Registration Statement
- 616-294-1026 (dollar_amount) — Business phone number
FAQ
What is the purpose of Shoulder Innovations, Inc.'s S-1/A filing?
The S-1/A filing by Shoulder Innovations, Inc. on July 25, 2025, is Amendment No. 3 to its S-1 Registration Statement, indicating the company's intent to register securities for a proposed sale to the public, likely an initial public offering (IPO). This is a critical step in becoming a publicly traded company.
Who are the key executives listed in Shoulder Innovations, Inc.'s S-1/A filing?
The S-1/A filing lists Robert Ball as the Chief Executive Officer and Executive Chairman, and Jeffrey Points as the Chief Financial Officer for Shoulder Innovations, Inc. Both are based at the company's principal executive offices in Grand Rapids, Michigan.
What industry does Shoulder Innovations, Inc. operate in according to the S-1/A?
According to the S-1/A filing, Shoulder Innovations, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its Standard Industrial Classification (SIC) Code 3841. This places them in the medical device sector.
When was Shoulder Innovations, Inc.'s S-1/A filed with the SEC?
Shoulder Innovations, Inc.'s S-1/A was filed with the U.S. Securities and Exchange Commission on July 25, 2025, as Amendment No. 3 to its original S-1 Registration Statement.
What is the business address for Shoulder Innovations, Inc.?
The business address for Shoulder Innovations, Inc. is 1535 Steele Avenue SW, Suite B, Grand Rapids, Michigan 49507, with a business phone number of (616) 294-1026.
Which law firms are involved in Shoulder Innovations, Inc.'s S-1/A filing?
The S-1/A filing indicates that Latham & Watkins LLP, Cooley LLP, and Honigman LLP are providing legal counsel for Shoulder Innovations, Inc. in connection with this registration statement.
What is the SEC file number for Shoulder Innovations, Inc.'s registration statement?
The SEC file number for Shoulder Innovations, Inc.'s registration statement under the Securities Act of 1933 is 333-288549, as stated in the S-1/A filing.
Is Shoulder Innovations, Inc. considered an emerging growth company?
The provided excerpt from the S-1/A filing does not explicitly state whether Shoulder Innovations, Inc. is a large accelerated filer, accelerated filer, non-accelerated filer, smaller reporting company, or an emerging growth company, as the relevant checkbox section is not marked.
What is the state of incorporation for Shoulder Innovations, Inc.?
Shoulder Innovations, Inc. is incorporated in Delaware, as specified in its charter and noted in the S-1/A filing.
What is the approximate date of the proposed sale to the public for Shoulder Innovations, Inc.?
The approximate date of commencement of the proposed sale to the public for Shoulder Innovations, Inc. is stated as 'As soon as practicable after the effective date of this Registration Statement' in the S-1/A filing.
Industry Context
Shoulder Innovations, Inc. operates within the Surgical & Medical Instruments & Apparatus industry (SIC 3841). This sector is characterized by innovation in medical technology, stringent regulatory oversight, and a competitive landscape driven by product efficacy and market adoption. Companies in this space often focus on developing specialized devices for orthopedic procedures, aiming to improve patient outcomes and surgeon efficiency.
Regulatory Implications
As a medical device company pursuing an IPO, Shoulder Innovations, Inc. is subject to rigorous SEC regulations for public companies and ongoing compliance with FDA regulations for its products. The S-1/A filing itself is a key regulatory step, requiring comprehensive disclosure of business operations, financial health, and potential risks.
What Investors Should Do
- Review the full S-1/A filing for detailed financial statements and risk disclosures.
- Analyze the company's competitive positioning within the shoulder replacement or related orthopedic device market.
Key Dates
- 2025-07-25: Filing of Amendment No. 3 to S-1 Registration Statement — Indicates the company is progressing towards its initial public offering and has provided updated information to the SEC.
Glossary
- S-1/A
- An amendment to an S-1 Registration Statement, which is filed with the SEC by companies intending to go public. It contains detailed information about the company's business, financial condition, management, and the proposed offering. (This filing signifies Shoulder Innovations, Inc.'s formal step towards becoming a publicly traded company.)
- SIC Code 3841
- Standard Industrial Classification code for Surgical & Medical Instruments & Apparatus. This categorizes companies involved in the manufacturing of medical, surgical, and dental instruments. (Classifies Shoulder Innovations, Inc. within the medical device manufacturing sector, providing context for its industry and competitors.)
- Registration Statement
- A document required by the U.S. Securities and Exchange Commission (SEC) that provides disclosure of material information about a company offering securities to the public. (The S-1/A is an update to the initial registration statement, showing progress in the IPO process.)
Year-Over-Year Comparison
As this is Amendment No. 3 to the S-1 Registration Statement, specific year-over-year financial comparisons are not directly available from this filing excerpt. However, the filing indicates a progression in the company's journey towards becoming a public entity, suggesting ongoing operational development and strategic planning since its initial S-1 filing.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on July 25, 2025 by Robert Ball regarding SHOULDER INNOVATIONS, INC. (SI).